Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
09/2003
09/18/2003CA2478701A1 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino) pyrimidine with cdk inhibitory activity
09/18/2003CA2478276A1 Azepane derivatives and their use as atk1 inhibitors
09/18/2003CA2478065A1 Macrocyclic compounds useful as pharmaceuticals
09/18/2003CA2477984A1 Pyrrole-2, 5-dione derivatives and their use as gsk-3 inhibitors
09/17/2003EP1343780A1 Piperazine derivatives for treatment of bacterial infections
09/17/2003EP1343779A2 Novel compounds
09/17/2003EP1343778A2 Di-substituted aminomethyl chroman derivative beta-3 adrenoreceptor agonists
09/17/2003EP1343775A2 Piperazine derivatives
09/17/2003EP1343765A1 Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperazine-containing moiety and their use as antibacterial agents
09/17/2003EP1343761A1 Piperidine mch antagonists and their use in the treatment of obesity
09/17/2003EP1343760A2 Muscarinic antagonists
09/17/2003EP1343751A2 Cyclic derivatives as modulators of chemokine receptor activity
09/17/2003EP1343505A1 Cxcr3 antagonists
09/17/2003EP1224174B1 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists
09/17/2003EP1196411B1 Bradykinin b1 receptor antagonists
09/17/2003EP1183241B1 Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
09/17/2003EP1027359B9 Monocyclic l-nucleosides, analogs and uses thereof
09/17/2003EP1023267B1 Pyridyl compounds and pharmaceutical compositions containing them
09/17/2003EP0941217B1 Symmetrical triazine derivatives
09/17/2003EP0909184B1 Targeted drug delivery using sulfonamide derivatives
09/17/2003EP0889034B1 Aminopyridine derivatives
09/17/2003EP0754682B9 Aminostilbazole derivative and medicine
09/17/2003CN1443191A Methods and compositions for treating hepatitis c virus
09/17/2003CN1443181A Phenyl-substituted 5,6-dihydropyrone derivatives for use as pesticides and herbicides
09/17/2003CN1443175A Process for preparation of 4,6-dimethoxy-2-(methylsulfonyl)-1,3-pyrimidine
09/17/2003CN1443170A Capsaicin receptor ligands
09/17/2003CN1443167A Azacyclic compounds for use in treatment of 5-serotonin related diseases
09/17/2003CN1443164A Pyrrolidine derivatives as metalloprotease inhibitors
09/17/2003CN1443163A Pyrrolidine-2-carboxylic acid hydrozide derivatives for use as metalloprotease inhibitors
09/17/2003CN1443160A N-substituted-1-amino-1,1-dialkyl carboxylic acid derivatives
09/17/2003CN1121398C Alicyclic acylated heterocyclic derivatives
09/17/2003CN1121396C Substituted phenyltriazolin (thi) ones and their use as herbicides
09/17/2003CN1121389C Cyanoguanidines as cell proliferation inhibitors
09/17/2003CN1121386C Chemical process for reduction of 1-substituted-3-hydroxymethy1-4-(4-fluorophenyl)
09/17/2003CN1121376C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives and matrix metalloprotease inhibitors
09/17/2003CN1121219C Novel process for manufacturing paroxetine solid dispersions
09/16/2003US6620839 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
09/16/2003US6620827 PPARγ modulators
09/16/2003US6620826 N-phenyl imidazole derivatives; cardiovascular disorders, hypotensive agents, kidney failure
09/16/2003US6620823 Antiinflammatory agents; rheumatic disorders
09/16/2003US6620821 HMG-CoA reductase inhibitors and method
09/16/2003US6620820 Inhibitors of bone reabsorption and antagonists of vitronectin receptors
09/16/2003CA2309711C N-hydroxyurea derivative and pharmaceutical composition containing the same
09/16/2003CA2232116C Novel n-aryl piperidine compounds, process for their preparation and pharmaceutical compositions containing them
09/16/2003CA2231025C Novel compounds of 2-aminoindane, process for their preparation and pharmaceutical compositions containing them
09/16/2003CA2167408C Process for making hiv protease inhibitors
09/16/2003CA2142610C Anabaseine derivatives useful in the treatment of degenerative diseases of the nervous system
09/16/2003CA2046429C Imide derivatives, and their production and use
09/16/2003CA2037575C N-(4-piperidinyl) (dihydrobenzofuran or dihydro-2h-benzopyran) carboxamide derivatives
09/12/2003WO2003075091A1 Colour photographic recording material
09/12/2003WO2003074519A1 Coumarines useful as biomarkers
09/12/2003WO2003074515A1 Diamino-pyrimidines and their use as angiogenesis inhibitors
09/12/2003WO2003074513A2 Indole amide derivatives and their use as glycogen phosphorylase inhibitors
09/12/2003WO2003074508A1 Compounds and methods of treating cell proliferative diseases
09/12/2003WO2003074497A1 Pin1-modulating compounds and methods of use thereof
09/12/2003WO2003074495A1 Hppars activators
09/12/2003WO2003074491A1 O-cyclopropyl-carboxanilides and their use as fungicides
09/12/2003WO2003074483A1 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
09/12/2003WO2003074475A2 Substituted aryl ketones
09/12/2003WO2003074467A2 Urea derivatives as hiv aspartyl protease inhibitors
09/12/2003WO2003074047A1 Indole derivatives as modulators of potassium channels
09/12/2003WO2003073987A2 Compounds that modulate the activity of ptp-1b and tc-ptp
09/12/2003WO2003045942A3 Chemokine receptor antagonists and methods of use thereof
09/12/2003WO2002058695A9 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
09/12/2003WO2002004443A3 Heterocycle carboxamides as antiviral agents
09/12/2003WO2001083800A9 Heterologous production of polyketides
09/12/2003CA2477715A1 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient
09/12/2003CA2477505A1 Diamino-pyrimidines and their use as angiogenesis inhibitors
09/12/2003CA2477119A1 Compounds that modulate the activity of ptp-1b and tc-ptp
09/12/2003CA2477003A1 Compounds and methods of treating cell proliferative diseases
09/12/2003CA2472298A1 Coumarines useful as biomarkers
09/11/2003WO2003074500A2 N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as ddp-iv inhibitors
09/11/2003WO2003074493A1 5-substituted-alkylaminopyrazole derivatives as pesticides
09/11/2003WO2003074492A2 5-substituted-alkylaminopyrazole derivatives as pesticides
09/11/2003WO2003074046A1 Antidepressant
09/11/2003US20030171588 And 3-carboxylic acids and derivatives; preparation from a resin bound aldehyde or diamine
09/11/2003US20030171461 Process for the synthesis of amine ethers from secondary amino oxides
09/11/2003US20030171429 Anti-inflammatory and psoriasis treatment and protein kinase inhibition by hydroxyltilbenes and novel stilbene derivatives and analogues
09/11/2003US20030171428 Anticancer agents; anticholesterol agents; cognition activators; rheumatic diseases
09/11/2003US20030171413 Rheumatic diseases; antiarthritic agents; asthma
09/11/2003US20030171411 Amide derivatives as therapeutic agents
09/11/2003US20030171406 Medicinal compositions containing propenone derivatives
09/11/2003US20030171404 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors
09/11/2003US20030171403 Blockade of voltage dependent sodium channels
09/11/2003US20030171400 Rheumatic diseases; osteoporosis; multiple sclerosis; autoimmune disease; joint replacements
09/11/2003US20030171362 Amino-tetralin derivatives as muscarinic receptor antagonists
09/11/2003US20030171360 Piperidines
09/11/2003US20030171359 Suitable for treatment of illnesses characterised by excessive or abnormal cell proliferation; viral, bacterial, fungal and/or parasitic infections, skin diseases, bone diseases, cardiovascular diseases
09/11/2003US20030171354 Indole derivatives
09/11/2003US20030171309 Pharmaceutically active pyrrolidine derivatives as bax inhibitors
09/11/2003US20030171219 2,4,5-trisubstituted phenylketo-enols for use as pesticides and herbicides
09/11/2003US20030168970 Luminescent element material and luminescent element comprising the same
09/10/2003EP1342720A2 Epoxysuccinamide derivatives
09/10/2003EP1341786A1 Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain
09/10/2003EP1341785A2 HYDROLYSIS OF R(R*,R*)]-2-(4-FLUOROPHENYL)-$g(b),$g(d) -DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4- (PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID ESTERS WITH CALCIUM HYDROXIDE
09/10/2003EP1341773A2 Substituted 1,3,5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis
09/10/2003EP1341771A2 Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors
09/10/2003EP1341769A2 Bacterial gyrase inhibitors and uses thereof
09/10/2003EP1341765A1 Therapeutic compounds
09/10/2003EP1341763A2 N-alkoxy-4,4-dioxy-polyalkyl-piperidine compounds, with glycidyl or alkylcarbonyl groups as functional initiators for controlled radical polymerization
1 ... 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 ... 694